China Universal Asset Management Company’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Buy
4,000
+800
+25% +$384K 0.12% 132
2026
Q1
$1.57M Sell
3,200
-785
-20% -$426K 0.12% 131
2025
Q4
$2.31M Buy
3,985
+22
+0.6% +$12.4K 0.18% 96
2025
Q3
$1.92M Buy
+3,963
New +$1.84M 0.16% 115
2025
Q2
Sell
-2,126
Closed -$1.06M 498
2025
Q1
$1.06M Buy
2,126
+235
+12% +$127K 0.1% 177
2024
Q4
$984K Buy
1,891
+519
+38% +$285K 0.09% 164
2024
Q3
$849K Buy
1,372
+781
+132% +$462K 0.09% 152
2024
Q2
$327K Sell
591
-185
-24% -$106K 0.05% 181
2024
Q1
$451K Buy
+776
New +$435K 0.06% 192

Other funds holding TMO

China Universal Asset Management Company's TMO Position: Q2 2026 in Review

China Universal Asset Management Company increased its Thermo Fisher Scientific (TMO) stake by 25% in Q2 2026, buying an estimated $384K and bringing the position to 4,000 shares worth $2.01M. The position accounts for 0.12% of the portfolio, ranked #132.

China Universal Asset Management Company first reported a position in TMO in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.31M in Q4 2025. 2,022 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • China Universal Asset Management Company held 4,000 shares of Thermo Fisher Scientific worth $2.01M as of Q2 2026.
  • China Universal Asset Management Company bought 800 Thermo Fisher Scientific shares in Q2 2026, an estimated $384K.
  • Thermo Fisher Scientific made up 0.12% of China Universal Asset Management Company's portfolio in Q2 2026, its #132 holding.
  • China Universal Asset Management Company first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 9 quarters since.
  • China Universal Asset Management Company's Thermo Fisher Scientific position peaked at $2.31M in Q4 2025.
  • 2,022 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.